{"mainPropery":{"diseaseId":2152,"diseaseName":"Junctional epidermolysis bullosa","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/2152/junctional-epidermolysis-bullosa","synonyms":["JEB","Epidermolysis bullosa, junctional","Epidermolysis bullosa atrophicans"],"synonyms-with-source":[{"name":"JEB"},{"name":"Epidermolysis bullosa, junctional"},{"name":"Epidermolysis bullosa atrophicans"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"305"},{"identifierType":"UMLS","identifierId":"C0079301"}]},"diseaseCategories":[],"organizations":[{"resourceID":93,"resourceName":"Dystrophic Epidermolysis Bullosa Research Association of America","abbreviation":"DEBRA of America","address1":"75 Broad Street","address2":"Suite 300","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10004","country":"United States","phone":"212-868-1573","tty":"","tollFree":"855-CURE-4-EB","fax":"212-868-9296","email":"staff@debra.org","url":"http://www.debra.org"},{"resourceID":696,"resourceName":"Epidermolysis Bullosa Center","abbreviation":"","address1":"The EB Center","address2":"Cincinnati Children's Hospital Medical Center","address3":"MLD 3004","address4":"3333 Burnet Avenue","address5":"","city":"Cincinnati","state":"OH","zip":"45229-3039","country":"United States","phone":"513-636-2009","tty":"","tollFree":"","fax":"","email":"ebcenter@cchmc.org","url":"https://www.cincinnatichildrens.org/service/e/epidermolysis-bullosa","freeText":""},{"resourceID":2754,"resourceName":"Epidermolysis Bullosa Medical Research Foundation","abbreviation":"EBMRF","address1":"2757 Anchor Ave","address2":"","address3":"","address4":"","address5":"","city":"Los Angeles","state":"CA","zip":"90064","country":"","phone":"+1-310-205-5119","tty":"","tollFree":"","fax":"","email":"a.pett@bep-la.com","url":"https://ebmrf.org/","freeText":""}],"resource descriptions":[{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Junctional+epidermolysis+bullosa%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Junctional epidermolysis bullosa. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/junctional-epidermolysis-bullosa' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Junctional epidermolysis bullosa. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":343,"resourceId":1160,"resourceName":"RareConnect- Epidermolysis Bullosa","descriptionText":"<a href='http://www.rareconnect.org/en/community/epidermolysis-bullosa ' target='_blank'>RareConnect</a> is an online social network for patients and families to connect with one another and share their experience living with a rare disease. The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders). Click on the link above to view the community for Epidermolysis bullosa.","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/001457.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=305' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK1125/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:3209' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2563,"resourceId":716,"resourceName":"DebRA International","descriptionText":"<a href='http://www.debra-international.org/clinical-guidelines.html' target='_blank'>DebRA International</a> has developed clinical practice guidelines for epidermolysis bullosa which provide recommendations for clinical care.&nbsp;These clinical guidelines are for patients as well as healthcare professionals.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Junctional epidermolysis bullosa. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Junctional epidermolysis bullosa:<br />\r\n<a href='https://ebcare.patientcrossroads.org/' target='_blank'>EBCare Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":4971,"questionText":"What is Junctional epidermolysis bullosa (JEB)?","answerText":"<strong>Junctional epidermolysis bullosa </strong>(JEB) is a type of <a href=\"http://rarediseases.info.nih.gov/GARD/Condition/6359/Epidermolysis_bullosa.aspx\" target=\"_blank\">Epidermolysis Bullosa</a>, a group of genetic conditions that cause the skin to be very fragile and to blister easily. &nbsp;JEB is separated into two categories: the <a href=\"http://rarediseases.info.nih.gov/GARD/Condition/2153/JEBH.aspx\" target=\"_blank\">Herlitz type</a><a target=\"_blank\"></a> and the <a href=\"http://rarediseases.info.nih.gov/GARD/Condition/2151/JEBnH.aspx\" target=\"_blank\">Non-Herlitz type</a>.[3965] The Herlitz type of JEB is very severe, and individuals with this condition often do not survive infancy.&nbsp;The Non-Herlitz type includes several subtypes that&nbsp;cause mild to severe blistering of the skin present at birth or shortly thereafter. [3966][3967]&nbsp;&nbsp;JEB is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> pattern. It is caused by mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/LAMB3\" target=\"_blank\">LAMB3</a></em>, <em><a href=\"http://ghr.nlm.nih.gov/gene/COL17A1\" target=\"_blank\">COL17A1</a></em>, or <em><a href=\"http://ghr.nlm.nih.gov/gene/LAMC2\" target=\"_blank\">LAMC2</a></em>, and <em><a href=\"http://ghr.nlm.nih.gov/gene/LAMA3\" target=\"_blank\">LAMA3</a></em> genes.[3965]There is no cure for JEB. Treatment is focused on management of blistering and prevention of secondary infections.[3966]","dateModified":"2016-02-09T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":6359,"relatedDiseaseName":"Epidermolysis bullosa","relation":"Parent","isRare":true,"hasGardPage":true},{"relatedDiseaseId":12922,"relatedDiseaseName":"Generalized junctional epidermolysis bullosa, non-Herlitz type","relation":"Child","isRare":true,"hasGardPage":false},{"relatedDiseaseId":2151,"relatedDiseaseName":"Junctional epidermolysis bullosa generalized intermediate","relation":"Child","isRare":true,"hasGardPage":false},{"relatedDiseaseId":2143,"relatedDiseaseName":"Junctional epidermolysis bullosa inversa","relation":"Child","isRare":true,"hasGardPage":false},{"relatedDiseaseId":9694,"relatedDiseaseName":"Junctional epidermolysis bullosa with pyloric atresia","relation":"Child","isRare":true,"hasGardPage":false},{"relatedDiseaseId":2153,"relatedDiseaseName":"Junctional epidermolysis bullosa, Herlitz type","relation":"Child","isRare":true,"hasGardPage":false},{"relatedDiseaseId":368,"relatedDiseaseName":"Laryngoonychocutaneous syndrome","relation":"Child","isRare":true,"hasGardPage":false},{"relatedDiseaseId":12921,"relatedDiseaseName":"Late-onset junctional epidermolysis bullosa","relation":"Child","isRare":true,"hasGardPage":false},{"relatedDiseaseId":12923,"relatedDiseaseName":"Localized junctional epidermolysis bullosa, non-Herlitz type","relation":"Child","isRare":true,"hasGardPage":false}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Junctional_epidermolysis_bullosa"}